WO2006003330A3 - Collections de composes tracables et leurs utilisations - Google Patents

Collections de composes tracables et leurs utilisations Download PDF

Info

Publication number
WO2006003330A3
WO2006003330A3 PCT/FR2005/001502 FR2005001502W WO2006003330A3 WO 2006003330 A3 WO2006003330 A3 WO 2006003330A3 FR 2005001502 W FR2005001502 W FR 2005001502W WO 2006003330 A3 WO2006003330 A3 WO 2006003330A3
Authority
WO
WIPO (PCT)
Prior art keywords
traceable
unknown
collections
compounds
cationic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2005/001502
Other languages
English (en)
Other versions
WO2006003330A2 (fr
Inventor
Marcel Francois Louis Hibert
Christel Anne Franchet
Jean-Luc Galzi
Franc Emile Jean Pattus
Fabrice Yves Guillier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Université de Strasbourg
Original Assignee
Centre National de la Recherche Scientifique
Université de Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique, Université de Strasbourg filed Critical Centre National de la Recherche Scientifique
Priority to CA2569553A priority Critical patent/CA2569553C/fr
Priority to EP05778653A priority patent/EP1756579B1/fr
Priority to US11/597,903 priority patent/US20070249013A1/en
Priority to AT05778653T priority patent/ATE459884T1/de
Priority to DE602005019730T priority patent/DE602005019730D1/de
Priority to AU2005259045A priority patent/AU2005259045B2/en
Publication of WO2006003330A2 publication Critical patent/WO2006003330A2/fr
Publication of WO2006003330A3 publication Critical patent/WO2006003330A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Radiation Diagnosis (AREA)

Abstract

La présente invention concerne l'utilisation d'une collection de composés traçables de type cationique, pour la détermination de ligands d'un récepteur dont on ne connaît pas de ligand ou dont on ne connaît pas de ligand utilisable pour les études de liaison d'affinité spécifique, lesdits composés traçables de type cationique étant caractérisés en ce qu'ils comprennent au moins un résidu d'acide aminé à caractère basique conférant le type cationique audit composé et un groupement traceur, notamment un fluorophore, un colorant ou un 'quencher'.
PCT/FR2005/001502 2004-06-15 2005-06-15 Collections de composes tracables et leurs utilisations Ceased WO2006003330A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA2569553A CA2569553C (fr) 2004-06-15 2005-06-15 Collections de composes tracables et leurs utilisations
EP05778653A EP1756579B1 (fr) 2004-06-15 2005-06-15 Collections de composes tracables et leurs utilisations
US11/597,903 US20070249013A1 (en) 2004-06-15 2005-06-15 Collections of Traceable Compounds and Uses Thereof
AT05778653T ATE459884T1 (de) 2004-06-15 2005-06-15 Sammlungen aus verfolgbaren verbindungen und verwendung dafür
DE602005019730T DE602005019730D1 (de) 2004-06-15 2005-06-15 Sammlungen aus verfolgbaren verbindungen und verwendung dafür
AU2005259045A AU2005259045B2 (en) 2004-06-15 2005-06-15 Collections of traceable compounds and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0406462 2004-06-15
FR0406462A FR2871464B1 (fr) 2004-06-15 2004-06-15 Collections de composes tracables et leurs utilisations

Publications (2)

Publication Number Publication Date
WO2006003330A2 WO2006003330A2 (fr) 2006-01-12
WO2006003330A3 true WO2006003330A3 (fr) 2006-10-26

Family

ID=34950289

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2005/001502 Ceased WO2006003330A2 (fr) 2004-06-15 2005-06-15 Collections de composes tracables et leurs utilisations

Country Status (8)

Country Link
US (1) US20070249013A1 (fr)
EP (1) EP1756579B1 (fr)
AT (1) ATE459884T1 (fr)
AU (1) AU2005259045B2 (fr)
CA (1) CA2569553C (fr)
DE (1) DE602005019730D1 (fr)
FR (1) FR2871464B1 (fr)
WO (1) WO2006003330A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2871465B1 (fr) * 2004-06-15 2006-09-08 Centre Nat Rech Scient Cnrse Collections de composes tracables et leurs utilisations
EP2164997A4 (fr) * 2007-04-10 2011-08-17 Univ Montana State Nouvelles molécules de marquage optique en protéomique et autres analyses biologiques
PL3160985T3 (pl) * 2014-06-30 2021-12-27 Flamma S.P.A. Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylo-l-fenyloalaninoamidu

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900658A (en) * 1986-04-11 1990-02-13 Hoechst Aktiengesellschaft Chromophoric peptides for detecting peptidylglycine-α-amidizing monooxygenase
WO1997007402A1 (fr) * 1995-08-17 1997-02-27 The Ontario Cancer Institute Methode de controle de l'assemblage des fibrilles de proteine
FR2764387A1 (fr) * 1997-06-05 1998-12-11 Centre Nat Rech Scient Utilisation d'une proteine fluorescente pour la detection d'interactions entre une proteine cible et son ligand
US5854216A (en) * 1994-09-23 1998-12-29 Universite De Montreal Marker for growth hormone-releasing factor receptors
US5916877A (en) * 1994-10-18 1999-06-29 Georgia Tech Research Corporation Fluorescent 1-peptidylaminoalkanephosphonate derivatives
WO2000023463A2 (fr) * 1998-10-16 2000-04-27 The Board Of Trustees Of The Leland Stanford Junior University Peptides se liant a des teintures fluorescentes
US20020034766A1 (en) * 2000-04-28 2002-03-21 Wei Huang Molecular modification assays

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US234766A (en) * 1880-11-23 Nut-lock
FR2871465B1 (fr) * 2004-06-15 2006-09-08 Centre Nat Rech Scient Cnrse Collections de composes tracables et leurs utilisations

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900658A (en) * 1986-04-11 1990-02-13 Hoechst Aktiengesellschaft Chromophoric peptides for detecting peptidylglycine-α-amidizing monooxygenase
US5854216A (en) * 1994-09-23 1998-12-29 Universite De Montreal Marker for growth hormone-releasing factor receptors
US5916877A (en) * 1994-10-18 1999-06-29 Georgia Tech Research Corporation Fluorescent 1-peptidylaminoalkanephosphonate derivatives
WO1997007402A1 (fr) * 1995-08-17 1997-02-27 The Ontario Cancer Institute Methode de controle de l'assemblage des fibrilles de proteine
FR2764387A1 (fr) * 1997-06-05 1998-12-11 Centre Nat Rech Scient Utilisation d'une proteine fluorescente pour la detection d'interactions entre une proteine cible et son ligand
WO2000023463A2 (fr) * 1998-10-16 2000-04-27 The Board Of Trustees Of The Leland Stanford Junior University Peptides se liant a des teintures fluorescentes
US20020034766A1 (en) * 2000-04-28 2002-03-21 Wei Huang Molecular modification assays

Also Published As

Publication number Publication date
CA2569553A1 (fr) 2006-01-12
FR2871464B1 (fr) 2006-09-08
AU2005259045B2 (en) 2011-09-01
EP1756579A2 (fr) 2007-02-28
ATE459884T1 (de) 2010-03-15
DE602005019730D1 (de) 2010-04-15
EP1756579B1 (fr) 2010-03-03
CA2569553C (fr) 2014-02-04
US20070249013A1 (en) 2007-10-25
FR2871464A1 (fr) 2005-12-16
WO2006003330A2 (fr) 2006-01-12
AU2005259045A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
WO2005023986A3 (fr) Micro-arn utilises comme ligands et molecules cibles
WO2007103770A3 (fr) Compositions et procedes pour l'analyse du cancer du rein
WO2007002540A3 (fr) Pegylation radiomarquee de ligands destines a etre utilises comme agents d'imagerie
WO2004085989A3 (fr) Compositions de colorant presentant des caracteristiques ameliorees de fluorescence differentielle et de diffusion de la lumiere
WO2001062979A3 (fr) Procede permettant d'identifier des agonistes partiels du recepteur a¿2a?
WO2005017205A3 (fr) Cartographie de l'acide nucleique par une analyse lineaire
EP1863810A4 (fr) NOUVEAUX DERIVES DE TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE UTILISES COMME LIGANDS DU RECEPTEUR CB1'
DE602004028125D1 (de) 1-sulfonylindolderivate, verfahren zu ihrer herstellung und ihre verwendung als 5-ht6 liganden
ATE298757T1 (de) Ternärligand-komplexe verwendbar als radiopharmazeutika
WO2000062074A8 (fr) Utilisation d'imagerie par resonance magnetique 13c pour la detection de liaisons
WO2003072033A3 (fr) Mimetiques de ligands communs: thiazolidinediones et rhodanines
WO2005000207A3 (fr) Anticorps du recepteur du pcdgf et procede d'utilisation associe
WO2003102541A3 (fr) Biocapteur universel et procedes d'utilisation
WO2006032441A3 (fr) Substances a colorant marque defini de maniere stoechiometrique destinees a mesurer le taux de filtration, leurs productions et leur utilisation
WO2002029409A3 (fr) Procede pour doser des composes biologiques contenant du pyrrole
WO2008040441A3 (fr) Radiofluoration
FR2871464B1 (fr) Collections de composes tracables et leurs utilisations
HK1052532A1 (zh) α(2)巨球蛋白受體作為熱沖擊蛋白受體及其用途
WO2001085779A3 (fr) Complexes proteiques et dosages de criblage d'agents anticancereux
WO2000077208A3 (fr) Nouveaux recepteurs gustatifs des drosophiles
WO2004039963A3 (fr) Anticorps specifiques de substrat-1/2 (ser 1101/ser1149) de recepteur d'insuline phosphoryle et utilisations associees
WO2007022086A3 (fr) Anticorps et methodes permettant de prevoir la formation de caries dentaires
WO2003042234A3 (fr) Ligands non peptidiques du recepteur de la somatostatine
WO2003057732A3 (fr) Ligands cibles
WO2007051603A3 (fr) Kit pour essais de detection a haute sensibilite

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005778653

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2005259045

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2569553

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2005259045

Country of ref document: AU

Date of ref document: 20050615

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005259045

Country of ref document: AU

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 2005778653

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11597903

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 11597903

Country of ref document: US